Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenium ions refer to selenium in its various ionic states (primarily selenide Se²⁻, selenite SeO₃²⁻, and selenate SeO₄²⁻). Selenium is a nonmetal element (atomic number 34, symbol Se) that is essential for human health as a component of selenoproteins involved in antioxidant defense and thyroid hormone metabolism[1][2][5][6]. Selenium ions are never themselves therapeutic targets like receptors or enzymes, but are instead incorporated into biomolecules or administered as supplements to treat or prevent selenium deficiency. Selenium status is relevant in various diseases, with roles both as an essential micronutrient and a potential toxicant at higher concentrations[2][5][6].
Incorporated in selenoproteins (e.g., glutathione peroxidase) through dietary uptake; functions as cofactor in redox and antioxidant activities
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenium ion (Se²⁻, Se⁴⁺, Se⁶⁺ (depending on oxidation state; no single canonical abbreviation)).